Mangoceuticals (MGRX) Institutional Ownership $2.47 +0.14 (+6.01%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Mangoceuticals (NASDAQ:MGRX)CurrentInstitutional OwnershipPercentage56.72%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$46.38MNumber ofInstitutional Sellers(last 12 months)0 Get MGRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Mangoceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Mangoceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/24/2024 Ackerman Capital Advisors LLC873,356$206K0.1%N/A3.519% 8/8/2023 Colonial River Wealth Management LLC36,100$66K0.0%N/A0.216% 7/28/2023 Independent Advisor Alliance26,000$48K0.0%N/A0.162% (Data available from 1/1/2016 forward) MGRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MGRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Mangoceuticals shares: Ackerman Capital Advisors LLC ($206K), and Colonial River Wealth Management LLC ($66K), Independent Advisor Alliance ($48K).Learn more on MGRX's institutional investors. What percentage of Mangoceuticals stock is owned by institutional investors? 56.72% of Mangoceuticals stock is owned by institutional investors. Learn more on MGRX's institutional investor holdings. Which institutional investors have been buying Mangoceuticals stock? The following institutional investors have purchased Mangoceuticals stock in the last 24 months: Ackerman Capital Advisors LLC ($873.36K), Colonial River Wealth Management LLC ($36.10K), and Independent Advisor Alliance ($26K). How much institutional buying is happening at Mangoceuticals? Institutional investors have bought a total of 935,456 shares in the last 24 months. This purchase volume represents approximately $71.94M in transactions. Related Companies CCM Major Shareholders OPGN Major Shareholders PMD Major Shareholders TOI Major Shareholders BRTX Major Shareholders OTRK Major Shareholders KDLY Major Shareholders BGLC Major Shareholders CMAX Major Shareholders ACON Major Shareholders This page (NASDAQ:MGRX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mangoceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
